Company Description
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey.
It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events.
The company was founded in 2006 and is based in Waltham, Massachusetts.
| Country | United States |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 136 |
| CEO | William J. Febbo |
Contact Details
Address: 260 Charles Street, Suite 302 Waltham, Massachusetts 02453 United States | |
| Phone | 248-651-6558 |
| Website | optimizerx.com |
Stock Details
| Ticker Symbol | OPRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001448431 |
| CUSIP Number | 68401U204 |
| ISIN Number | US68401U2042 |
| Employer ID | 26-1265381 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| William J. Febbo | Chief Executive Officer and Director |
| Stephen L. Silvestro | President |
| Edward Stelmakh C.M.A., M.B.A. | Chief Financial Officer and Chief Operating Officer |
| Andrew Jacob D'Silva | Senior Vice President of Corporate Finance |
| Todd Inman | Chief Technology Officer |
| Marion K Odence-Ford | General Counsel and Chief Compliance Officer |
| Maira Alejandra | Media Relations Manager |
| Sheryl Kearney | Human Resources Manager |
| Terence J. Hamilton | Senior Vice President of Pharma |
| Dr. Doug Besch | Chief Product Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jun 7, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |
| May 14, 2024 | 8-K | Current Report |
| Apr 29, 2024 | 8-K | Current Report |
| Apr 29, 2024 | ARS | Filing |
| Apr 29, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 18, 2024 | 8-K | Current Report |
| Apr 15, 2024 | 10-K | Annual Report |